Medtronic, Olympus Corporation, BD are dominating the market for Global Airway Management Device Market in 2019

Airway Management Device Market is expected to grow at a healthy CAGR of 5.5% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report at https://www.databridgemarketresearch.com/reports/global-airway-management-device-market

Global airway management device market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased various strategic developments owing to favourable market scenario.

The major players dealing in global airway management device market are introducing strong range of product portfolio. This has also helped the company to maximize the sales with enhanced product portfolio. For instance, in January, Olympus Corporation launched a transforming program to accelerate its growth as a leading medical technology with improved performance and value creation for all shareholders. This will help the company to enhance its organic growth and operations.  

Medtronic is the dominating player in the airway management device market. The other key players existing in the market includes Olympus Corporation, BD, Smiths Group plc, Medline Industries, Inc., Halma plc, GENERAL ELECTRIC, SonarMed, Mercury Medical, KARL STORZ, Smiths Group plc , Verathon Inc., VBM Medizintechnik GmbH, SunMed, MEDTRONIC, Flexicare (Group) Limited, VYAIRE , Ambu A/S, Intersurgical Ltd, Teleflex Incorporated.

MEDTRONIC

Medtronic is headquartered in Dublin, Ireland which was founded in 1949. The company develops and manufactures a wide range of products and therapies including implantable mechanical devices, drug & biologic delivery devices, and advanced energy surgical instruments. The company business segments are Medical, Scientific Solutions, Imaging, Others and market focused is Medical. The company’s product categories are Anesthesiology, Bariatrics, ENT, Gastroenterology, General Surgery, Gynecology, Neurosurgery, Pulmonology, Thoracic Surgery, and Urology

In June 2018, Medtronic participated in the Goldman Sachs 39th Annual Global Healthcare Conference which was held on 12th June in Rancho Palos Verdes, U.S. This would help the company in enhancing its value creation amongst the customer

The company has wide global presence across the globe such as Americas, Europe, Africa, Middle East, Asia-Pacific. In addition to it, the company also generates its revenue from the various subsidiary companies such Covidien (Irish), Corventis,Inc. (U.S.), TyRx Pharma Inc.(U.S.), ATS Medical (U.S.),Given Imaging (Israel), and United States Surgical Corporation (U.S.) among others.

OLYMPUS CORPORATION

Olympus Corporation headquartered in Tokyo, Japan which was founded in 1919. The company offers therapeutics and diagnostic solutions including surgical endoscopy systems, gastrointestinal endoscopes and other peripherals for less invasive therapy. The company business segments are Cardiac and Vascular Group, Minimally Invasive Therapies Group, Pain Therapies. And market focused is Minimally Invasive Therapies Group. The coapnys product categories are Advanced Energy and Stapling, Gastrointestinal and Hepatology, General Surgery, Lung Health, Patient Monitoring, Renal Care, Respiratory, Visualization

For instance,

  • In January 2019, Olympus Corporation launched a transforming program to accelerate its growth as a leading medical technology with improved performance and value creation for all shareholders. This will help the company to enhance its organic growth and operations

The company has wide global presence across the globe such as North America, Europe, Asia-Pacific, South Africa. In addition to it, the company also generates its revenue from the various subsidiary companies such as KeyMed (U.K.), Olympus Europa SE & Co. KG (Germany), Gyrus ACMI, Inc. (U.S.), Olympus Medical Systems Corp. (Japan), Olympus Corporation of the Americas (U.S.) among others.

BD

BD has headquartered in New Jersey, U.S.  And it was founded in 1897. The company develops, manufacture and distributor of medical supplies, devices, laboratory equipment and diagnostic products. The company business segments are Medical, Life Sciences, Interventional and market focused is Medical. The company’s product categories are Bowel Management, Continence - Incontinence Solutions, Gastric Management, Kidney & Stone Management, Patient Monitoring, Patient Temperature Management Systems, Prostate Health, Respiratory Management, Urological Drainage, Vascular Patency, Wound Management

  • In December 2017, BD acquired C. R. Bard, Inc. with annualized revenue of USD 16.0 billion approximately. The acquisition has helped the company to strengthen its product portfolio in clinical areas and to become leader in global healthcare market

The company has presence in Eastern Europe, the Middle East, Africa, Latin America, Asia-Pacific. In addition to it, the company also generates its revenue from the various subsidiary companies such as CareFusion (U.S.), C. R. Bard (U.S), Accuri Cytometers Inc. (U.S), TVA Medical, Inc.  (U.S.), Becton Dickinson AcuteCare Inc.  (West Africa), TriPath Imaging, Inc. (U.S.) among others.

Recent Strategic Decisions

Airway Management Device Market